Home › Funds › CPP Investments › JNJ

CPP Investments position in JNJ

JOHNSON & JOHNSON · Health Care

CPP Investments reported holding 5,105,914 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$1.35B, representing 0.75% of its reported portfolio and ranking #21 among its reported holdings. CPP Investments has disclosed JNJ holdings in 21 of the last 21 reported quarters, going back to Q3 2021.

Latest position (Q3 2026)5.11M sh
Reported value held$1.35B
Portfolio Weight0.75%
First reportedQ3 2021
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How CPP Investments's JNJ position evolved

CPP Investments first disclosed a stake in JNJ in Q3 2021 at 5,474,671 shares (US$884.2M). The position peaked in Q3 2026 at 5,105,914 shares, worth US$1.35B. Across 21 filings, CPP Investments increased the stake 12 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 5,105,914 shares valued at US$1.35B — a reduction of -178,300 shares quarter over quarter.. Notable position changes include a 31% trim in Q4 2021 (shares rose 4% over the following quarter), a 28% increase in Q1 2023 (shares rose 7% over the following quarter), a 39% trim in Q1 2025 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2021 5.47M $884.16M New
Q4 2021 3.78M $646.55M Reduce
Q1 2022 3.46M $612.46M Reduce
Q2 2022 3.31M $586.80M Reduce
Q3 2022 3.01M $492.09M Reduce
Q4 2022 2.40M $424.74M Reduce
Q1 2023 3.08M $478.01M Add
Q2 2023 3.31M $547.90M Add
Q3 2023 2.60M $405.11M Reduce
Q4 2023 2.78M $436.36M Add
Q1 2024 3.49M $551.63M Add
Q2 2024 4.00M $584.17M Add
Q3 2024 4.24M $687.86M Add
Q4 2024 4.53M $654.84M Add
Q1 2025 2.78M $460.87M Reduce
Q2 2025 2.95M $450.13M Add
Q3 2025 3.48M $645.19M Add
Q4 2025 3.55M $735.62M Add
Q1 2026 4.54M $1.11B Add
Q2 2026 5.28M $1.34B Add
Q3 2026 5.11M $1.35B Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$55.52B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has CPP Investments held JNJ?

CPP Investments has disclosed JNJ holdings in 21 of the last 21 reported quarters, going back to Q3 2021.

What is CPP Investments's current position in JNJ?

As of Q3 2026, CPP Investments holds 5.11M shares of JNJ (JOHNSON & JOHNSON), valued at $1.35B, representing 0.75% of its reported portfolio and ranking #21.

Has CPP Investments been buying or selling JNJ?

In the latest 13F filing (Q3 2026), CPP Investments reduced its position in JNJ. The position peaked in Q3 2026 at 5.11M shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.